Live tape
Top 8, mentions 7d7,186NVDA1,232 mentions▲ +0.10GOOGL1,075 mentions▲ +0.04AVGO1,020 mentions▲ +0.05NKE1,004 mentions+0.02LULU950 mentions▲ +0.03TSLA828 mentions▲ +0.06META573 mentions▲ +0.06MSFT504 mentions▲ +0.07

Equity · Healthcare

WGS

GeneDx Holdings Corp. · NasdaqGS

$85.93 −1.23% 1D Finazon · prior-day close · Sep 4, 2026
Price · Chart
Our own end-of-day closes 55 sessions
$100 $40 10 Jun 4 Sep

The line runs $54.33 on 10 June through $85.93 on 4 September, on a scale from $40 to $100. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of WGS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 55 sessions over that window: $54.33 on 10 June 2026 through $85.93 on 4 September 2026.

Market cap $2.6B
52-week range $34 – $167.69
Avg volume 89.6K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 8, 2026

WGS insider trades

SEC Form 4 · last 90 days · newest reported trade 1 Sep 2026
Open-market buys 0
Open-market sells 3
Net sold $896K
Non-trade filings 9
Date Insider Type Shares Value
01 Sep 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Sell 372 $31K
16 Jun 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Sell 3,729 $227K
16 Jun 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER Sell 10,501 $638K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Sep 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Option exercise 717
18 Jun 2026 Casdin Eli Director Option exercise 3,576
18 Jun 2026 RUCH JOSHUA Director Option exercise 3,576
18 Jun 2026 PFENNIGER RICHARD C JR Director Option exercise 3,576
18 Jun 2026 Meister Keith A. Director Option exercise 3,576
18 Jun 2026 Ryan Jason Director Option exercise 3,576
18 Jun 2026 Leproust Emily M. Director Option exercise 3,576
16 Jun 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Option exercise 7,197
16 Jun 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER Option exercise 18,750

WGS reported financials

SEC EDGAR XBRL

WGS reported revenue of $427.5M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$21.0M.

Figure Reported Period
Revenue $427.5M 31 Dec 2025 fiscal year
Net income −$21.0M 31 Dec 2025 fiscal year
Diluted EPS −$0.73 31 Dec 2025 fiscal year
Total assets $481.5M 30 Jun 2026 at period end
Total equity $244.2M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

WGS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.60 $114M
31 Mar 2026 Q1 2026 $-2.16 $102M
31 Dec 2025 FY 2025 $-0.73 $428M
30 Sep 2025 Q3 2025 $-0.27 $117M
30 Jun 2025 Q2 2025 $0.36 $103M
31 Mar 2025 Q1 2025 $-0.23 $87M
31 Dec 2024 FY 2024 $-1.94 $305M
30 Sep 2024 Q3 2024 $-0.31 $77M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

WGS institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a WGS position for the quarter ended 30 Jun 2026 — a combined $528.7M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Corvex Management Added +48.2% shares 4,784,570 $328.5M
ARK Investment Management Held (±25%) +21.6% shares 1,610,189 $110.5M
Citadel Advisors Added +33.7% shares 865,462 $59.4M
Millennium Management Held (±25%) +3.8% shares 155,575 $10.7M
Tudor Investment Corp Added +224.5% shares 108,839 $7.5M
Point72 Asset Management Added +28.4% shares 97,300 $6.7M
D. E. Shaw & Co. Added +105.7% shares 38,877 $2.7M
AQR Capital Management Added +58.6% shares 29,172 $2.0M
Two Sigma Investments Held (±25%) +2.3% shares 10,684 $733K
Man Group Exited

Source: SEC EDGAR 13F filings

WGS fails-to-deliver

SEC CNS data

On 10 Aug 2026, 306 shares of WGS failed to deliver (about $24K).

Settlement date Shares failed Notional % of shares out
10 Aug 2026 306 $24K 0.001%
06 Aug 2026 1,442 $101K 0.005%
05 Aug 2026 405 $29K 0.001%
03 Aug 2026 60 $4K <0.001%

Source: SEC fails-to-deliver (CNS) data